EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry

Gastón A Ghio iD, Marta Domínguez-Álvaro iD, Iñigo Hernández Rodríguez, Elisa Fernández-Fernández, Maite Silva-Díaz iD, Joaquín M Belzunegui, Clara Moriano iD, Julio Sánchez Martín, Javier Narváez iD, Eva Galíndez Agirregoikoa, Anne Riveros Frutos, Francisco Ortiz Sanjuán iD und 10 weitere

Nutrients · 2025

DOI: 10.3390/nu17203291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Gastón A Ghio und 21 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Hospital Universitari Mùtua de Terrassa, 08221 Barcelona, Spain. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Glucocorticoids, Vitamin D, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Farma, Spain, S.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether oral vitamin D supplementation reduces the risk of glucocorticoid (GC)-associated severe adverse events (SAEs) in patients with giant cell arteritis (GCA) included in the Spanish ARTESER registry.

Methods

The ARTESER registry collected data from patients diagnosed with GCA across 26 Spanish public hospitals between June 2013 and March 2019. SAEs were defined as fatal, life-threatening, or requiring hospitalization. Patients were categorized according to the use or non-use of oral vitamin D supplements. Incidence rates (IRs) of SAEs were expressed per person-year with 95% confidence intervals (CIs). Cox proportional hazards models assessed vitamin D supplementation and its interaction with cumulative glucocorticoid dose.

Results

Of 1568 patients (mean age 76.9 ± 8.1 years; 70.1% women) receiving GC, 120 (7.6%) experienced SAEs (IR 0.039; 95% CI 0.033–0.047). Vitamin D supplementation was documented in 1186 (75.6%) compared with 382 (24.4%) non-supplemented patients. SAE incidence was similar in supplemented (n = 89; 7.5%; IR 0.038, 95% CI 0.030–0.046) and non-supplemented patients (n = 31; 8.1%; IR 0.045, 95% CI 0.031–0.064) (p = 0.387). Multivariable Cox regression showed a significant interaction between vitamin D supplementation and cumulative glucocorticoid dose (interaction term HR 0.90; p = 0.033), consistent with a dose-dependent protective effect.

Conclusions

Vitamin D supplementation was not independently associated with a lower incidence of GC-related SAEs, likely due to residual confounding factors. However, the interaction with cumulative GC exposure suggests a modulatory effect. Prospective studies incorporating stratified baseline vitamin D assessments are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisGlucocorticoidsVitamin DDietary SupplementsHumansFemaleMaleAgedRegistriesSpainAged, 80 and overIncidenceProportional Hazards ModelsMiddle Aged

Stichwörter der Autor:innen

adverse drug reactionsgiant cell arteritisglucocorticoidssupplementationvitamin D

Substanzen

GlucocorticoidsVitamin D

Autor:innen und Institutionen

  • Rheumatology Department, Hospital Universitari Mùtua de Terrassa, 08221 Barcelona, Spain.
  • Research Unit, Sociedad Española de Reumatología, 28001 Madrid, Spain.
  • Rheumatology Department, Complejo Hospitalario Universitario de Vigo, 36312 Galicia, Spain.
  • Rheumatology Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
  • Rheumatology Department, Complejo Hospitalario Universitario de A Coruña, 15006 La Coruna, Spain.
  • Rheumatology Department, Hospital Universitario Donosti, 20014 Donostia, Spain.

ORCID-Profile: Gastón A Ghio, Marta Domínguez-Álvaro, Maite Silva-Díaz, Clara Moriano, Javier Narváez, Francisco Ortiz Sanjuán, Carlota L Iñiguez, Clara Molina Almela, María Alcalde Villar, José L Hernández, Santos Castañeda, Ricardo Blanco

Förderung

  • Roche Farma, Spain, S.A.

Zitieren

APA

Ghio, G. A., Domínguez-Álvaro, M., Rodríguez, I. H., Fernández-Fernández, E., Silva-Díaz, M., Belzunegui, J. M., Moriano, C., Martín, J. S., Narváez, J., Agirregoikoa, E. G., Riveros Frutos, A., Ortiz Sanjuán, F., Salman Monte, T. C., Vasques Rocha, M., Iñiguez, C. L., García Dorta, A., Molina Almela, C., Alcalde Villar, M., Hernández, J. L., …, & ARTESER Project Collaborative Group (2025). Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry. Nutrients. https://doi.org/10.3390/nu17203291

Vancouver

Ghio GA, Domínguez-Álvaro M, Rodríguez IH, Fernández-Fernández E, Silva-Díaz M, Belzunegui JM, et al. Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry. Nutrients. 2025. doi:10.3390/nu17203291

BibTeX
@article{Ghio2025,
  author = {Ghio, Gastón A and Domínguez-Álvaro, Marta and Rodríguez, Iñigo Hernández and Fernández-Fernández, Elisa and Silva-Díaz, Maite and Belzunegui, Joaquín M and Moriano, Clara and Martín, Julio Sánchez and Narváez, Javier and Agirregoikoa, Eva Galíndez and Riveros Frutos, Anne and Ortiz Sanjuán, Francisco and Salman Monte, Tarek C and Vasques Rocha, Margarida and Iñiguez, Carlota L and García Dorta, Alicia and Molina Almela, Clara and Alcalde Villar, María and Hernández, José L and Castañeda, Santos and Blanco, Ricardo and ARTESER Project Collaborative Group, ARTESER Project Collaborative Group},
  title = {Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17203291}
}
Kostenlos starten →